Cargando…

Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation

OBJECTIVES: To investigate the effects of l‐dopa (Levodopa) and cZi‐DBS (deep brain stimulation in caudal zona incerta) on spontaneous speech intelligibility in patients with PD (Parkinson's disease). MATERIALS AND METHODS: Spontaneous utterances were extracted from anechoic recordings from 11...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandström, Linda, Hägglund, Patricia, Johansson, Louise, Blomstedt, Patric, Karlsson, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614054/
https://www.ncbi.nlm.nih.gov/pubmed/26516614
http://dx.doi.org/10.1002/brb3.394
_version_ 1782396353205239808
author Sandström, Linda
Hägglund, Patricia
Johansson, Louise
Blomstedt, Patric
Karlsson, Fredrik
author_facet Sandström, Linda
Hägglund, Patricia
Johansson, Louise
Blomstedt, Patric
Karlsson, Fredrik
author_sort Sandström, Linda
collection PubMed
description OBJECTIVES: To investigate the effects of l‐dopa (Levodopa) and cZi‐DBS (deep brain stimulation in caudal zona incerta) on spontaneous speech intelligibility in patients with PD (Parkinson's disease). MATERIALS AND METHODS: Spontaneous utterances were extracted from anechoic recordings from 11 patients with PD preoperatively (off and on l‐dopa medication) and 6 and 12 months post bilateral cZi‐DBS operation (off and on stimulation, with simultaneous l‐dopa medication). Background noise with an amplitude corresponding to a clinical setting was added to the recordings. Intelligibility was assessed through a transcription task performed by 41 listeners in a randomized and blinded procedure. RESULTS: A group‐level worsening in spontaneous speech intelligibility was observed on cZi stimulation compared to off 6 months postoperatively (8 adverse, 1 positive, 2 no change). Twelve months postoperatively, adverse effects of cZi‐DBS were not frequently observed (2 positive, 3 adverse, 6 no change). l‐dopa administered preoperatively as part of the evaluation for DBS operation provided the overall best treatment outcome (1 adverse, 4 positive, 6 no change). CONCLUSIONS: cZi‐DBS was shown to have smaller negative effects when evaluated from spontaneous speech compared to speech effects reported previously. The previously reported reduction in word‐level intelligibility 12 months postoperatively was not transferred to spontaneous speech for most patients. Reduced intelligibility due to cZi stimulation was much more prominent 6 months postoperatively than at 12 months.
format Online
Article
Text
id pubmed-4614054
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-46140542015-10-29 Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation Sandström, Linda Hägglund, Patricia Johansson, Louise Blomstedt, Patric Karlsson, Fredrik Brain Behav Original Research OBJECTIVES: To investigate the effects of l‐dopa (Levodopa) and cZi‐DBS (deep brain stimulation in caudal zona incerta) on spontaneous speech intelligibility in patients with PD (Parkinson's disease). MATERIALS AND METHODS: Spontaneous utterances were extracted from anechoic recordings from 11 patients with PD preoperatively (off and on l‐dopa medication) and 6 and 12 months post bilateral cZi‐DBS operation (off and on stimulation, with simultaneous l‐dopa medication). Background noise with an amplitude corresponding to a clinical setting was added to the recordings. Intelligibility was assessed through a transcription task performed by 41 listeners in a randomized and blinded procedure. RESULTS: A group‐level worsening in spontaneous speech intelligibility was observed on cZi stimulation compared to off 6 months postoperatively (8 adverse, 1 positive, 2 no change). Twelve months postoperatively, adverse effects of cZi‐DBS were not frequently observed (2 positive, 3 adverse, 6 no change). l‐dopa administered preoperatively as part of the evaluation for DBS operation provided the overall best treatment outcome (1 adverse, 4 positive, 6 no change). CONCLUSIONS: cZi‐DBS was shown to have smaller negative effects when evaluated from spontaneous speech compared to speech effects reported previously. The previously reported reduction in word‐level intelligibility 12 months postoperatively was not transferred to spontaneous speech for most patients. Reduced intelligibility due to cZi stimulation was much more prominent 6 months postoperatively than at 12 months. John Wiley and Sons Inc. 2015-09-25 /pmc/articles/PMC4614054/ /pubmed/26516614 http://dx.doi.org/10.1002/brb3.394 Text en © 2015 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Sandström, Linda
Hägglund, Patricia
Johansson, Louise
Blomstedt, Patric
Karlsson, Fredrik
Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation
title Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation
title_full Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation
title_fullStr Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation
title_full_unstemmed Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation
title_short Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation
title_sort speech intelligibility in parkinson's disease patients with zona incerta deep brain stimulation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614054/
https://www.ncbi.nlm.nih.gov/pubmed/26516614
http://dx.doi.org/10.1002/brb3.394
work_keys_str_mv AT sandstromlinda speechintelligibilityinparkinsonsdiseasepatientswithzonaincertadeepbrainstimulation
AT hagglundpatricia speechintelligibilityinparkinsonsdiseasepatientswithzonaincertadeepbrainstimulation
AT johanssonlouise speechintelligibilityinparkinsonsdiseasepatientswithzonaincertadeepbrainstimulation
AT blomstedtpatric speechintelligibilityinparkinsonsdiseasepatientswithzonaincertadeepbrainstimulation
AT karlssonfredrik speechintelligibilityinparkinsonsdiseasepatientswithzonaincertadeepbrainstimulation